Skip to main content
Top
Published in: Virology Journal 1/2010

Open Access 01-12-2010 | Methodology

A novel method for purifying bluetongue virus with high purity by co-immunoprecipitation with agarose protein A

Authors: Song Zhen, Dong Changyuan, Wang Lulu, Chen Dong-E, Bi Guoming, Dai Ming, Liu Jun

Published in: Virology Journal | Issue 1/2010

Login to get access

Abstract

Background

Bluetongue virus (BTV) is an icosahedral non-enveloped virus within the genus Orbivirus of Reoviridae and exists as 24 distinct serotypes. BTV can infect all ruminant species and causes severe sickness in sheep. Recently, it was reported that BTV can infect some human cancer cells selectively. Because of the important oncolysis of this virus, we developed a novel purifying method for large-scale production. The purifying logic is simple, which is picking out all the components unwanted and the left is what we want. The process can be summarized in 4 steps: centrifugation, pulling down cell debrises and soluble proteins by co-immunoprecipitation with agarose Protein A, dialysis and filtration sterilization after concentration.

Results

The result of transmission electron microscope (TEM) observation showed that the sample of purified virus has a very clear background and the virions still kept intact. The result of 50% tissue culture infective dose (TCID50) assay showed that the bioactivity of purified virus is relatively high.

Conclusions

This method can purify BTV-10 with high quality and high biological activity on large-scale production. It also can be used for purifying other BTV serotypes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pritchard LI, Gould AR: Phylogenetic comparison of the serotype-specific VP2 protein of bluetongue and related orbiviruses. Virus Res 1995, 39: 2-3. 10.1016/0168-1702(95)00094-1CrossRef Pritchard LI, Gould AR: Phylogenetic comparison of the serotype-specific VP2 protein of bluetongue and related orbiviruses. Virus Res 1995, 39: 2-3. 10.1016/0168-1702(95)00094-1CrossRef
2.
go back to reference Oldfield S, Hirasawa T, Roy P: Sequence conservation of the outer capsid protein, VP5, of bluetongue virus, a contrasting feature to the outer capsid protein VP2. J Gen Virol 1991, 72: 449-51. 10.1099/0022-1317-72-2-449PubMedCrossRef Oldfield S, Hirasawa T, Roy P: Sequence conservation of the outer capsid protein, VP5, of bluetongue virus, a contrasting feature to the outer capsid protein VP2. J Gen Virol 1991, 72: 449-51. 10.1099/0022-1317-72-2-449PubMedCrossRef
3.
go back to reference Wilson WC, Ma HC, Venter EH, van Djik AA, Seal BS, Mecham JO: Phylogenetic relationships of bluetongue viruses based on gene S7. Virus Res 2000,67(2):141-51. Erratum in: Virus Res. 73 201-2 10.1016/S0168-1702(00)00138-6PubMedCrossRef Wilson WC, Ma HC, Venter EH, van Djik AA, Seal BS, Mecham JO: Phylogenetic relationships of bluetongue viruses based on gene S7. Virus Res 2000,67(2):141-51. Erratum in: Virus Res. 73 201-2 10.1016/S0168-1702(00)00138-6PubMedCrossRef
4.
go back to reference Jun H, Dong CY, Li KK, Chen DE, Liang K, Liu J: Selective in vitro cytotoxic effect of human cancer cells by Bluetongue virus-10. Acta Oncol 2008, 47: 124-134. 10.1080/02841860701403038CrossRef Jun H, Dong CY, Li KK, Chen DE, Liang K, Liu J: Selective in vitro cytotoxic effect of human cancer cells by Bluetongue virus-10. Acta Oncol 2008, 47: 124-134. 10.1080/02841860701403038CrossRef
5.
go back to reference Nason EL, Rothagel R, Mukherjee SK, Kar AK, Forzan M, Prasad BV, Roy P: Interactions between the inner and outer capsids of bluetongue virus. J Virol 2004, 78: 8059-8067. 10.1128/JVI.78.15.8059-8067.2004PubMedPubMedCentralCrossRef Nason EL, Rothagel R, Mukherjee SK, Kar AK, Forzan M, Prasad BV, Roy P: Interactions between the inner and outer capsids of bluetongue virus. J Virol 2004, 78: 8059-8067. 10.1128/JVI.78.15.8059-8067.2004PubMedPubMedCentralCrossRef
6.
go back to reference Huismans H, Van Der Walt NT, Cloete M, Erasmus BJ: Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep. Virology 1987, 61: 3589-3595. Huismans H, Van Der Walt NT, Cloete M, Erasmus BJ: Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep. Virology 1987, 61: 3589-3595.
7.
go back to reference Mertens PPC, Burroughs JN, Anderson J: Purification and properties of virus particles, infectious subviral particles, and cores of bluetongue virus serotype 1 and 4. Virology 1987, 157: 375-386. 10.1016/0042-6822(87)90280-7PubMedCrossRef Mertens PPC, Burroughs JN, Anderson J: Purification and properties of virus particles, infectious subviral particles, and cores of bluetongue virus serotype 1 and 4. Virology 1987, 157: 375-386. 10.1016/0042-6822(87)90280-7PubMedCrossRef
8.
go back to reference Mertens PPC, Burroughs JN, Walton A, Welby MP, Fu H, O'Hara RS, Brookes SM, Mellor PS: Enhanced infectivities of modified bluetongue virus for two insect cell lines for two Culicoides vector species. Virology 1995, 217: 582-593. 10.1006/viro.1996.0153CrossRef Mertens PPC, Burroughs JN, Walton A, Welby MP, Fu H, O'Hara RS, Brookes SM, Mellor PS: Enhanced infectivities of modified bluetongue virus for two insect cell lines for two Culicoides vector species. Virology 1995, 217: 582-593. 10.1006/viro.1996.0153CrossRef
9.
go back to reference Roy P: Bluetongue virus proteins. J Gen Virol 1989, 73: 3051-3064. 10.1099/0022-1317-73-12-3051CrossRef Roy P: Bluetongue virus proteins. J Gen Virol 1989, 73: 3051-3064. 10.1099/0022-1317-73-12-3051CrossRef
10.
go back to reference Cowley JA, Gorman BM: Cross-neutralisation of genetic reassortants of bluetongue virus serotypes 20 and 21. Vet Microbiol 1989, 19: 37-51. 10.1016/0378-1135(89)90089-8PubMedCrossRef Cowley JA, Gorman BM: Cross-neutralisation of genetic reassortants of bluetongue virus serotypes 20 and 21. Vet Microbiol 1989, 19: 37-51. 10.1016/0378-1135(89)90089-8PubMedCrossRef
11.
go back to reference Mertens PPC, Pedley S, Cowley J, Burroughs JN, Corteyn AH, Jeggo MH, Jennings AM, Gorman BM: Analysis of the roles of bluetongue virus outer capsid proteins VP2 and VP5 in determination of virus serotype. Virology 1989, 170: 561-565. 10.1016/0042-6822(89)90447-9PubMedCrossRef Mertens PPC, Pedley S, Cowley J, Burroughs JN, Corteyn AH, Jeggo MH, Jennings AM, Gorman BM: Analysis of the roles of bluetongue virus outer capsid proteins VP2 and VP5 in determination of virus serotype. Virology 1989, 170: 561-565. 10.1016/0042-6822(89)90447-9PubMedCrossRef
12.
go back to reference Chen J, Hu J, Dong CY, Liang K, Dai Y, Gao J: Death mode of Hep-3B and A549 tumor cells induced by bluetongue virus strain HbC3. Zhonghua Zhong Liu Za Zhi 2007, 29: 505-9.PubMed Chen J, Hu J, Dong CY, Liang K, Dai Y, Gao J: Death mode of Hep-3B and A549 tumor cells induced by bluetongue virus strain HbC3. Zhonghua Zhong Liu Za Zhi 2007, 29: 505-9.PubMed
13.
go back to reference Xiang Luo, Changyuan Dong, Shufang Guo: Bluetongue Virus Therapy of MA782 Breast Adenocarcinom a Grown Subcutaneously in Mice. Volume 25. Medical Journal of Wuhan University; 2004:372-379. Xiang Luo, Changyuan Dong, Shufang Guo: Bluetongue Virus Therapy of MA782 Breast Adenocarcinom a Grown Subcutaneously in Mice. Volume 25. Medical Journal of Wuhan University; 2004:372-379.
14.
go back to reference Martin SA, Zweerink HJ: Isolation and characterization of two types of bluetongue virus particles. Virology 1972, 50: 495-506. 10.1016/0042-6822(72)90400-XPubMedCrossRef Martin SA, Zweerink HJ: Isolation and characterization of two types of bluetongue virus particles. Virology 1972, 50: 495-506. 10.1016/0042-6822(72)90400-XPubMedCrossRef
15.
16.
go back to reference Huismans H, Els HJ: Characterization of the tubules associated with the replication of three different orbiviruses. Virology 1979, 92: 397-406. 10.1016/0042-6822(79)90144-2PubMedCrossRef Huismans H, Els HJ: Characterization of the tubules associated with the replication of three different orbiviruses. Virology 1979, 92: 397-406. 10.1016/0042-6822(79)90144-2PubMedCrossRef
17.
go back to reference Coffey MC, Strong LE, Forsyth PA: Reovirus Therapy of Tumors with Activated Ras Pathway. Science 1998, 282: 1332-1334. 10.1126/science.282.5392.1332PubMedCrossRef Coffey MC, Strong LE, Forsyth PA: Reovirus Therapy of Tumors with Activated Ras Pathway. Science 1998, 282: 1332-1334. 10.1126/science.282.5392.1332PubMedCrossRef
18.
go back to reference Ahlert T, Schirrmacher V: Isolation of a human melanoma adapted Newcastle disease virus mutant with highly selective replication patterns. Cancer Res 1990, 50: 5962-5968.PubMed Ahlert T, Schirrmacher V: Isolation of a human melanoma adapted Newcastle disease virus mutant with highly selective replication patterns. Cancer Res 1990, 50: 5962-5968.PubMed
Metadata
Title
A novel method for purifying bluetongue virus with high purity by co-immunoprecipitation with agarose protein A
Authors
Song Zhen
Dong Changyuan
Wang Lulu
Chen Dong-E
Bi Guoming
Dai Ming
Liu Jun
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-7-126

Other articles of this Issue 1/2010

Virology Journal 1/2010 Go to the issue